Searched for
DERMATOLOGICAL SPACE
For investors with ability – and patience to wait 3 years, not 3 months: 6 large-cap stocks with upside potential of up to 33%The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- In 1888, a doctor’s daughter tired of body odor turned cream into a personal fix, and deodorant became part of modern routineBack in 1888, a groundbreaking cream named Mum made waves in the world of personal care, tackling the age-old issue of body odor. This inno...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- How an Australian connection helped Shaily Mehrotra build a Rs 1,500-crore Indian skincare brandA gap in science-backed skincare products in the Indian market prompted Shaily Mehrotra to start Fixderma, with an aim to solve common skin...
- Wealth creation is also about ignoring noise on the street: 15 mid- and small-cap stocks from different sectors which fit the billIn the April 2022-September 2024 bull market, every management appeared capable. Margins expanded, working capital looked manageable, capit...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Sun Pharma-Organon deal: How a $12-billion merger will reshape India's pharma landscapeSun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The ...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Pharmacy startup Plazza in talks to raise $12-15 million from Accel, Nexus, ElevationPlazza, a quick medicine delivery startup, is in talks to secure $12-15 million in funding. This new capital will help Plazza expand its ph...
- Eli Lilly forays into dermatological space with launch of psoriasis drugEli Lilly has launched a new drug to treat moderate-to-severe plaque psoriasis in India. The drug, Copellor, is designed to specifically ta...
- Torrent Pharma to acquire Sequoia-backed Curatio Health for ₹2,000 crCuratio's portfolio consists of over 50 brands, including Tedibar, Atogla, Spoo, B4 Nappi, and Permite, which are ranked among the top five...
- Torrent Pharmaceuticals to acquire 100% of Curatio Healthcare for Rs 2,000 croresSkincare product maker- Curatio has a strong presence in the cosmetic dermatology segment with a portfolio of over 50 brands, marketed in I...
- Skin ailments augment derma business in retail pharmaIncreasing incidence of fungal infections, greater awareness of skin-related issues and skin care and a growing desire to look presentable ...
- Dr Reddy's launches Sernivo spray in the US marketThis adds to another milestone for the Promius Pharma, committed to develop innovative treatment options in dermatology space, spray to be ...
- Dr Reddy's Laboratories gets USFDA approval to market Sernivo sprayThe company said its US subsidiary Promius Pharma has received USFDA approval to market Sernivo spray, used in treatment of skin disorder.
- Torrent Pharma rallies 5%, hits 52-week high on acquisition plansTorrent Pharma pared some of the morning gains but was still trading 3.5 per cent higher at Rs 1315.80. It hit a low of Rs 1306 and a high ...
- Chronic illness sees a spurt in business opportunity for pharma marketAccording to data from AIOCD, the Indian pharma market has grown at a compound annual growth rate of 3.3% in volume terms in the past five ...
- What Does Sun Pharma's September Quarter Performance Indicate?With Caraco resuming manufacturing at its facilities in Michigan, the company is likely to gradually recover any loss in revenues.
- Midcap best bets-Phillips Carbon Black, Glenmark: Satish Betadpur, Independent Intl Investment ResearchSatish Betadpur, CFA, Global Research Director, Independent International Investment Research, takes his picks on the midcap space on an ET...
Load More
